Insider · CIK 0001187314
Ulf Wiinberg
Files at AGEN (AGENUS INC), INKT (MiNK Therapeutics, Inc.). First filing Nov 17, 2023, latest Nov 17, 2023.
In brief
Ulf Wiinberg files SEC Form 4 as director at AGEN (AGENUS INC), and also at INKT (MiNK Therapeutics, Inc.). Since Nov 17, 2023, Ulf Wiinberg has reported 1 open-market buy worth $19k and 0 open-market sells worth $0, the latest filed on Nov 17, 2023.
A track record needs three past buys with six months of prices behind them; Ulf Wiinberg has 0, so none is measured yet.
The newest scored trade: bought $19k of AGEN on Nov 15, 2023, filed Nov 17, 2023, scored 21 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AGEN: AGENUS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | INKT MiNK Therapeutics, Inc. | AGrant or award Common Stock | +1,279 | $10.95 | $14k | 23,929 | 42 d ago |
| Mar 2, 2026 | INKT MiNK Therapeutics, Inc. | AGrant or award Common Stock | +1,285 | $10.90 | $14k | 21,519 | Jun 2, 2026 |
| Jun 1, 2026 | INKT MiNK Therapeutics, Inc. | AGrant or award Common Stock | +1,131 | $12.38 | $14k | 22,650 | Jun 2, 2026 |
| Jan 2, 2026 | INKT MiNK Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +5,395 | $0.00 | $0 | 5,395 | Jan 6, 2026 |
| Dec 1, 2025 | INKT MiNK Therapeutics, Inc. | AGrant or award Common Stock | +1,263 | $11.09 | $14k | 20,234 | Dec 3, 2025 |
| Sep 9, 2025 | INKT MiNK Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +3,225 | $0.00 | $0 | 3,225 | Sep 11, 2025 |
| Sep 2, 2025 | INKT MiNK Therapeutics, Inc. | AGrant or award Common Stock | +1,011 | $13.86 | $14k | 18,971 | Sep 3, 2025 |
| Jun 2, 2025 | INKT MiNK Therapeutics, Inc. | AGrant or award Common Stock | +1,953 | $7.17 | $14k | 17,960 | Jun 4, 2025 |
| Dec 1, 2024 | INKT MiNK Therapeutics, Inc. | AGrant or award Common Stock | +20,476 | $0.73 | $15k | 144,181 | Dec 3, 2024 |
| Jan 2, 2024 | AGEN AGENUS INC | AGrant or award Deferred Stock Unitsderivative | +30,956 | - | - | 240,486 | Jan 4, 2024 |
| Dec 1, 2023 | INKT MiNK Therapeutics, Inc. | AGrant or award Common Stock | +14,424 | $1.04 | $15k | 74,543 | Dec 5, 2023 |
| Nov 15, 2023 | AGEN AGENUS INC | POpen-market purchase Common Stock | +25,000 | $0.76 | $19k | 124,063 | Nov 17, 2023 |
Questions about Ulf Wiinberg
Answered from the filings on this page, as of the latest one.
Is Ulf Wiinberg buying or selling?
Not in the last 12 months. Ulf Wiinberg's latest open-market trade on SEC Form 4 was bought $19k of AGEN on Nov 15, 2023.
How did Ulf Wiinberg's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ulf Wiinberg has 0.
Where does Ulf Wiinberg file Form 4?
Ulf Wiinberg has filed Form 4 at AGEN (AGENUS INC); INKT (MiNK Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.